Which department should I go to when I go to the hospital for treatment of teratoma

Which department should I go to for treatment of teratoma? Since ovarian insensitivity syndrome is rare and the chance of pregnancy is very small, ovarian biopsy is generally not recommended. So, which department should I go to for treatment of teratoma? What are the treatment methods for ovarian teratoma? Let's take a look at the following introduction.

Teratoma is a common benign tumor in women. You need to go to the hospital to see a gynecologist. The expert will require you to undergo various examinations and receive corresponding treatment.

Once an ovarian teratoma is diagnosed, early detection and surgical resection are necessary to prevent the malignant transformation of benign teratoma due to delayed scientific research and surgery. Detection can also prevent tumor infection, rupture, bleeding and complications. The key point of teratoma surgery is to completely remove the tumor. For ovarian and testicular tumors, one ovary or testicle is removed. For sacrococcygeal teratoma, it is emphasized that the coccyx must be removed at the same time to avoid residual pluripotent cells and cause tumor recurrence.

The treatment principle of malignant ovarian teratoma is combined adjuvant therapy. After surgical resection, conventional chemotherapy is usually performed for 1.5 to 2 years, usually with cisplatin, vinblastine or vincristine, and bleomycin. Since 2006, combined chemotherapy with cisplatin, doxorubicin, ifosfamide and other chemotherapy drugs has been recommended. Radiotherapy is only used for cases of malignant teratoma with clear microscopic or macroscopic residues. The radiotherapy dose is preferably 25Gy for microscopic residues, and 35Gy for macroscopic residues. For those with complete surgical resection, chemotherapy has been advocated in recent years, and radiotherapy has been used with caution to avoid delayed damage to reproductive organs and bone development during radiotherapy.

For patients with large or extensively infiltrated malignant teratomas that are clinically judged to be unresectable, preoperative chemotherapy or radiotherapy can be used to shrink the tumor before delayed radical surgery, which is of positive significance in improving the surgical resection rate and preserving important organs. For advanced cases, preoperative chemotherapy or radiotherapy can also achieve the therapeutic goal of relieving tumor compression, controlling metastatic lesions, and gaining the opportunity for reoperation.

Ovarian teratomas are generally asymptomatic clinically, but may cause abdominal distension, mild abdominal pain and compression symptoms when they grow up. The contents of teratomas are composed of a variety of mature tissues from 2 to 3 germ layers, most of which are ectoderm tissues. Therefore, squamous epithelium, sebaceous glands, sweat glands, hair and mature nerve tissue, as well as mesoderm fat cartilage and bone tissue can be seen in the cyst. About half of ovarian dermoid cysts contain teeth.

Generally speaking, the prognosis of immature teratoma is poor, and surgery cannot guarantee complete and clean elimination of it, and there is a risk of recurrence. Benign teratoma has a better prognosis, and the possibility of malignant transformation is only 2 to 3 percent, and it does not affect ovarian function. After surgery, menstruation is normal, the pregnancy rate is normal, and there is no problem of recurrence.

In addition, CLS cell immunotherapy can also be used to treat ovarian teratoma, which is one of the effective treatment measures for ovarian teratoma. CLS cell immunotherapy can be used to treat cancer patients at all stages, especially those with advanced tumors, who have lost the opportunity for radiotherapy or have poor physical fitness, cannot tolerate high-dose radiotherapy, or are insensitive to radiotherapy and have drug resistance. Biological treatment alone can significantly improve symptoms, improve quality of life, and prolong survival time.